Sat.Apr 12, 2025

article thumbnail

Renal Outcomes Seem to Differ By Gender After Living Kidney Donation

Med Page Today

(MedPage Today) -- BOSTON -- After living kidney donation, projection of renal function may vary by gender, a retrospective cohort study of 174,311 living kidney donors suggested. Over a median 6.7 months, the incidence rate of worsening post.

Outcomes 104
article thumbnail

How trustworthy is your fitness tracker score?

Medical Xpress - Cardiology

Millions of people now start their day with a numbera "readiness" score, a "body battery"" level or a measure of "strain""delivered by the wearable device on their wrist or finger. But how much trust should we place in these scores?

82
article thumbnail

Insulin resistance quantified by estimated glucose disposal rate predicts cardiovascular disease incidence: a nationwide prospective cohort study

Cardiovascular Diabetology

Insulin resistance (IR) is an important pathologic component in the occurrence and development of cardiovascular disease (CVD). The estimated glucose disposal rate (eGDR) is a measure of glucose handling capac.

article thumbnail

Healthy Aging and Diet; Global Effect of Cardiovascular Risk Factors

Med Page Today

(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center.

article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

The HCPFive: Top News for Healthcare Providers from the Week of 04/06

HCPLive

Our top 5 headlines spotlight developments in AI-driven care, diabetes tech, and dermatology, alongside key FDA actions in ophthalmology and nephrology.

article thumbnail

Ventricular-Coronary Interaction Delay is Associated with Discordance Between Fractional Flow Reserve and Coronary Flow Reserve in Intermediate Coronary Stenoses

The American Journal of Cardiology

Publication date: Available online 11 April 2025 Source: The American Journal of Cardiology Author(s): Ahmet Tas, Yaren Alan, Alp Ozcan, Kim H Parker, Tim van de Hoef, Murat Sezer, Jan J Piek

40

More Trending

article thumbnail

Heart Disease Myths & Misconceptions

CTVS

Heart disease affects millions of Americans and remains the leading cause of death for both men and women year after year. It refers to the serious conditions affecting the heart, its operation and structure, and the many blood vessels, veins and arteries surrounding it.

article thumbnail

SAHVAI‐3D and 4D: Automated AI Volumetric Measurement of Subarachnoid Hemorrhage on Noncontrast Head CT

Stroke: Vascular and Interventional Neurology

Stroke: Vascular and Interventional Neurology, Ahead of Print. BACKGROUNDWe automated subarachnoid hemorrhage volume (SAHV) calculation with artificial intelligence (SAHVAI) and created 3dimensional volumetric images (SAHVAI3D) using noncontrast head computed tomography data for patients with aneurysmal SAH. We also defined 4dimensional SAHVAI (SAHVAI4D), representing SAHV over time.

article thumbnail

Besifovir Improves Renal, Bone Health in HBV Patients Receiving Long-Term TDF

HCPLive

Phase 4 trial results showed switching to BSV after long-term TDF was noninferior for antiviral efficacy and led to improved kidney function and bone density.

40
article thumbnail

LB-102 Significantly Improves Disease Severity in Acute Schizophrenia, with John Kane, MD

HCPLive

HCPLive spoke with Kane about new phase 2 data showing that an oral benzamide provides a significant change from baseline in CGI-S scores for participants with acute schizophrenia.

40